MacuSight Expands Management Team With Appointment of Dr. Joel Naor as Chief Medic...(ons he will make toMacuSight and our cli...),Health
Navigation Links
MacuSight Expands Management Team With Appointment of Dr. Joel Naor as Chief Medical Officer
Date:2/20/2008
ons he will make to MacuSight and our clinical programs."
Dr. Naor earned his M.D. from the Technion -- Israel Institute of Technology and underwent cornea and external disease training at the University of Toronto where he also obtained his M.Sc. in epidemiology. He holds a Masters of Business Administration from Simon Fraser University in Vancouver.
"I am thrilled to be joining a management team that has an impressive track record in identifying and advancing novel therapeutics in the area of ophthalmology and which is supported by a scientific advisory board of world-renowned experts," said Dr. Naor. "Clearly, we all believe in the great promise that sirolimus holds in treating various ocular diseases and conditions and I am confident in the ability of MacuSight to realize this potential and deliver a much needed therapeutic option to patients."
About MacuSight
MacuSight is a privately-held pharmaceutical company focused on developing innovative therapeutics for the treatment of severe ocular diseases and conditions. The company is dedicated to preserving patients' vision by identifying known, highly-potent and broad-acting small molecule drug compounds that may possess efficacy in treating and/or preventing diseases or conditions of the eye. As part of its unique product development philosophy, MacuSight also concentrates on the optimal delivery of these compounds into the eye. By combining its compounds with innovative delivery approaches, the company strives to optimize the efficacy, safety, convenience and cost-effectiveness of its product candidates.
The company's lead development program is centered on advancing sirolimus (rapamycin) as a potential next-generation therapeutic for the treatment and prevention of wet age-related macular degeneration (wet AMD) and the treatment of diabetic macular edema (DME), a manifestation of diabetic retinopathy.
'/>"/>
| SOURCE MacuSight, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Veteran Bariatric Surgeon Expands Services to Solano County
2. Tahitian Noni International Expands HIRO(TM) Beverage Line With Super Fruits Sparkling Black Currant
3. Convera(R) Expands Advanstar OnLine Business to Vertical Search Covering Pharmaceutical Industry Applications
4. Hondros College Expands School of Nursing to Columbus and Dayton; Students Can Begin LPN Education Almost Immediately
5. Beryl Expands Leadership Team, Adds Senior VP of Product Management and Marketing
6. Anthem Blue Cross and Blue Shield Expands Network of Hospitals to Serve Hoosier Healthwise Members
7. Henry Ford Hospital expands research on gene and radiation therapy for prostate cancer
8. HearAtLast Expands Chain to 18 Locations Opening New Clinic in Aurora, Ontario Wal-Mart Store # 5778
9. HearAtLast Expands Chain to 17 Locations, Opening New Clinic in Oshawa, Ontario Wal-Mart Supercenter # 1056
10. Cell Therapeutics, Inc. (CTI) Cuts Net Operating Expenses 35% and Expands Commercial Team to Support Zevalin(R) Sales and Applications Seeking Two Product Approvals in 2009
11. SAFC Pharma Expands Its Pharmorphix Solid State Chemistry Services
Post Your Comments:
(Date:11/8/2009)...are Reform Bill ,, Critical legislation would...ricans ,, CHICAGO, Nov. 7 /PRNewswire-USNewswi...atives passed by a vote of 220-215, critical healt...dicare for seniors and end discrimination by insur...ut of affordable health coverage. ,, The Affo...
(Date:11/7/2009)...re/ -- Karen Ignagni, President and CEO of America...lowing statement today on House passage of H.R. 39...sive health care reform, and we have contributed t... of how health insurance is provided. Earlier this...n of pre-existing condition exclusions, no longer ...
(Date:11/7/2009)...ok (GA), Louis J. Goodman (TX), Palmer P. Jones (N...ov. 7 The American Medi... society executive leaders with achievement awards...als of the medical profession. The awards were pre...ing in Houston. ,, (Logo: http://www.newscom...
(Date:11/7/2009)...ponsibility to vigorously oppose abortion in healt...INGTON, Nov. 7 Ameri... following statement on the news that Cardinal Jus...ordable Health Care for America Act (H.R. 3962), p... abortion is voted upon. ,, "Our Catholic bish...
(Date:11/7/2009)...ty of America (PRSA) will bestow the distinguished...e president of Brand Strategy, Communications and ... PRSA,s 2009 International Conference in San Diego...llows is one of the profession,s highest individua...PRSA, and 2009 chair of the College of Fellows. "I...
Breaking Medicine News(10 mins):Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3Health News:AHIP Statement on House Passage of H.R. 3962 2Health News:AMA Honors Medical Society Executives 2Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 3[0] AARP Illinois Key Vote News Alert[0] AHIP Statement on House Passage of H.R. 3962[0] AMA Honors Medical Society Executives[0] Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life[0] PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement
...LIN, N.J., April 21 Pharmos Corporation (Pink S... a private placement of common stock and warrants....ares of common stock and warrants exercisable for ...year term, is $0.12 per share. , , The three purc...
...Los Angeles Exposition Park , , LOS ANGE...Dimes premier fundraising event that benefits all ... to survive and thrive. 11,000 walkers are expecte...les, CA this Saturday, April 25. , , (Logo: http...
... YORK, April 21 Carl Icahn announced today that h... Jr., Chairman of the Board and James Wilson, Lead...nc. (Nasdaq: AMLN ) concerning recent discussion...irman of the Board, James Wilson, Lead Independ...
... YORK, April 21 Immtech Pharmaceuticals, Inc. (NY...is reorganizing its R&D operations. This restr...nities based on the Company,s ongoing discovery pr...l Development & Chief Medical Officer is being...
...ng contradicts belief that process favors people i...hDay News) -- People with kidney failure who live ...t a kidney transplant than people in urban areas, ...d 2007. After about two years on the list, 122,785...
... finds fewer complications with electrophysiologis...-- Chances are you,ve never heard of electrophysio...now about if you are one of the 100,000 or so Amer...rly. And the incidence of in-hospital complication...
Other Medicine News:Health News:Pharmos Completes Private Placement - Raises $1.8 Million 2Health News:Pharmos Completes Private Placement - Raises $1.8 Million 3Health News:Farmers Insurance Joins March of Dimes March for Babies April 25, 2009 2Health News:Icahn Responds to Cook and Wilson 2Health News:Icahn Responds to Cook and Wilson 3Health News:Icahn Responds to Cook and Wilson 4Health News:Immtech to Reorganize Research and Development Operations 2Health News:Immtech to Reorganize Research and Development Operations 3Health News:Distance No Bar to Kidney Transplants in Remote Areas 2Health News:Doctor's Training Affects Defibrillator Implant Results 2Health News:Doctor's Training Affects Defibrillator Implant Results 3Pharmos Completes Private Placement - Raises $1.8 MillionFarmers Insurance Joins March of Dimes March for Babies April 25, 2009Icahn Responds to Cook and WilsonImmtech to Reorganize Research and Development OperationsDistance No Bar to Kidney Transplants in Remote AreasDoctor's Training Affects Defibrillator Implant Results
(Date:11/6/2009)...ll/ -- Oxygen Biotherapeutics, Inc. (OTC Bulletin ...roved reverse split of its common stock will take ...2009 on a 1-for-15 split-adjusted basis. Oxygen Bi...w symbol OXBT. The stock also will have a new CUSI...ctive. ,, "This reverse split was overwhelmingl...
(Date:11/6/2009)...PRNewswire/ -- In consultation with the U.S. Food ...lthcare, Division of McNEIL-PPC, Inc., is initiati...ct lots of TYLENOL® Arthritis Pain Caplet 100...AP. McNeil is initiating the recall after identify...with these lots that led to a small number of cons...
(Date:11/6/2009)...Therapeutics, Inc. announced today that it has fil....S. Securities and Exchange Commission (SEC) relat...s of its common stock. All shares of the common st...the Company. ,, Credit Suisse Securities (USA) ...Jaffray & Co. is acting as co-lead manager and...
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 2Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 3McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL(R) Arthritis Pain 100 Count with EZ-OPEN CAP 2Video 3A New Insights Link Low HDL Cholesterol and Elevated Triglycerides with Coronary Heart Disease and Microvascular Complications in Patients at G 55865 1Video 3A New Insights Link Low HDL Cholesterol and Elevated Triglycerides with Coronary Heart Disease and Microvascular Complications in Patients at G 55865 2Video 3A New Insights Link Low HDL Cholesterol and Elevated Triglycerides with Coronary Heart Disease and Microvascular Complications in Patients at G 55865 3Video 3A New Insights Link Low HDL Cholesterol and Elevated Triglycerides with Coronary Heart Disease and Microvascular Complications in Patients at G 55865 4Video 3A New Insights Link Low HDL Cholesterol and Elevated Triglycerides with Coronary Heart Disease and Microvascular Complications in Patients at G 55865 5Video 3A New Insights Link Low HDL Cholesterol and Elevated Triglycerides with Coronary Heart Disease and Microvascular Complications in Patients at G 55865 6Video 3A New Insights Link Low HDL Cholesterol and Elevated Triglycerides with Coronary Heart Disease and Microvascular Complications in Patients at G 55865 7Video 3A New Insights Link Low HDL Cholesterol and Elevated Triglycerides with Coronary Heart Disease and Microvascular Complications in Patients at G 55865 8SIGVARIS USA Extends Educational Efforts in Healthy Advices Skin Care Network 55860 1SIGVARIS USA Extends Educational Efforts in Healthy Advices Skin Care Network 55860 2SIGVARIS USA Extends Educational Efforts in Healthy Advices Skin Care Network 55860 3New Medical Technology Company CareFusion Spins Off From Cardinal Health Begins Trading on NYSE 55856 1New Medical Technology Company CareFusion Spins Off From Cardinal Health Begins Trading on NYSE 55856 2[0] Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009[0] McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL(R) Arthritis Pain 100 Count with EZ-OPEN CAP[0] Trius Therapeutics Files Registration Statement for Proposed Initial Public Offering
...ating to Company Oncology Programs to be Presented...ewswire-FirstCall/ -- Cytokinetics, Incorporated a...inical data will be,presented at the 2007 Annual M...arch (AACR) to be held from April 14- 18, 2007 in,...iple oncology,programs at Cytokinetics and will pr...
...(BUSINESS WIRE)--Apr 10, 2007 - Inotek,Pharmaceuti...n the,journal Stroke of preclinical animal data sh...) polymerase (PARP) inhibitor,has a large protecti...ollowing a stroke. PARP is a nuclear enzyme that d...n and recruitment of DNA,repair enzymes and has po...
Other Medicine Technology:Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 2Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 3Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 4Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 5Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 6Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting 7Inotek Pharmaceuticals Announces Publication of Animal Data from,Study of PARP Inhibition as Potential Preventative of Brain Injury,Following Stroke 2Inotek Pharmaceuticals Announces Publication of Animal Data from,Study of PARP Inhibition as Potential Preventative of Brain Injury,Following Stroke 3| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |